VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Murata Manufacturing Co., Ltd. vs Eli Lilly and Company
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Murata Manufacturing Co., Ltd.
6981 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Murata Manufacturing Co., Ltd.'s moat claims, evidence, and risks.
View 6981 analysisEli Lilly and Company
LLY · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Eli Lilly and Company's moat claims, evidence, and risks.
View LLY analysisComparison highlights
- Moat score gap: Murata Manufacturing Co., Ltd. leads (75 / 100 vs 66 / 100 for Eli Lilly and Company).
- Segment focus: Murata Manufacturing Co., Ltd. has 6 segments (47.7% in Capacitors (primarily MLCC)); Eli Lilly and Company has 5 segments (65.5% in Cardiometabolic Health).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Murata Manufacturing Co., Ltd. has 8 moat types across 4 domains; Eli Lilly and Company has 5 across 2.
Primary market context
Murata Manufacturing Co., Ltd.
Capacitors (primarily MLCC)
Multilayer ceramic capacitors (MLCC) and related capacitors
Global
Electronics OEMs and tier-1 suppliers (smartphone, PC/server, automotive, industrial)
Component manufacturer / supplier
47.7%
Eli Lilly and Company
Cardiometabolic Health
Branded cardiometabolic pharmaceuticals (type 2 diabetes, obesity, and related metabolic/cardiovascular conditions; especially incretin therapies)
Global
Patients via prescribers; payers/PBMs; wholesaler & pharmacy channels
Drug developer, manufacturer, and marketer
65.5%
Side-by-side metrics
Moat coverage
Shared moat types
Murata Manufacturing Co., Ltd. strengths
Eli Lilly and Company strengths
Segment mix
Murata Manufacturing Co., Ltd. segments
Full profile >Capacitors (primarily MLCC)
Oligopoly
Inductors and EMI Filters
Oligopoly
High-Frequency Devices and Communications Modules
Oligopoly
Batteries and Power Supply
Competitive
Functional Devices (including sensors)
Competitive
Other
Competitive
Eli Lilly and Company segments
Full profile >Cardiometabolic Health
Oligopoly
Oncology
Competitive
Immunology
Competitive
Neuroscience
Competitive
Other
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.